Research Article
Laboratory Investigation (2006) 86, 951–958. doi:10.1038/labinvest.3700450; published online 17 July 2006
Global proteomic analysis of microdissected cirrhotic nodules reveals significant biomarkers associated with clonal expansion
Nathalie Guedj1, Delphine Dargere1, Françoise Degos2, Jean Louis Janneau1, Dominique Vidaud3, Jacques Belghiti4, Pierre Bedossa1,5 and Valerie Paradis1,5
- 1CNRS UMR 8149, Faculté de Pharmacie, Paris V, Paris, France
- 2Service d'Hépatologie, Hôpital Beaujon, Beaujon, France
- 3UPRES EA 3618, Faculté de Pharmacie, Paris V, Paris, France
- 4Service de Chirurgie hépatique, Hôpital Beaujon, Beaujon, France
- 5Service d'Anatomie pathologique, Hôpital Beaujon, Clichy Cedex, France
Correspondence: Dr V Paradis, MD, Service d'Anatomie pathologique, Hôpital Beaujon, 110 bd du général Leclerc, 92118 Clichy Cedex, France. E-mail: vparadis@teaser.fr
Received 29 December 2005; Revised 9 May 2006; Accepted 13 May 2006; Published online 17 July 2006.
Abstract
Cirrhosis is a heterogeneous tissue composed of polyclonal regenerative and monoclonal neoplastic, potentially malignant nodules from which hepatocellular carcinoma (HCC) might develop. The aim of this study was to investigate proteomic profile changes associated with clonal expansion of cirrhotic nodules and malignant transformation of monoclonal nodules. Seventy-one cirrhotic nodules from 10 female patients with six HCC were dissected from liver surgical specimen by laser capture microdissection. Clonal status of each nodule was assessed by the study of X-chromosome inactivation pattern using the human androgen receptor. Protein profiles were determined by surface-enhanced laser desorption ionisation-time-of-flight technology using Q10 arrays (Cyphergen ProteinChip®). Molecular weight of differentially expressed protein peaks was assessed. An average of 50 protein peaks was obtained for each nodule's profile. Comparison of protein profiles in polyclonal (n=45) and monoclonal cirrhotic nodules (n=26) identified three differentially expressed protein peaks (10 092, 54 025 and 62 133 Da). All were upregulated in monoclonal nodules. Twelve peaks were differentially expressed between monoclonal nodules and HCC with nine proteins upregulated in cancer samples. This study confirms that proteome analysis can be achieved from a limited number of microdissected cells, and provides further insight into the process of clonal expansion and malignant transformation of cirrhotic nodules.
Keywords:
cirrhosis, clonal analysis, hepatocellular carcinoma, HUMARA, proteomics
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Molecular pathogenesis of human hepatocellular carcinoma
Nature Genetics Progress (01 Aug 2002)
Technology Insight: the application of proteomics in gastrointestinal disease
Nature Clinical Practice Gastroenterology & Hepatology Review (01 Jul 2007)
Technology Insight: the application of proteomics in gastrointestinal disease
Nature Clinical Practice Gastroenterology & Hepatology Review (01 Jul 2007)
RESEARCH
Preparation of a quantum state with one molecule at each site of an optical lattice
Nature Physics Letter (01 Oct 2006)
Laboratory Investigation Article Response

